ArticleThe Journal of clinical endocrinology and metabolism2026

GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.

Aditya Mahadevan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.